Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations-Reference-Cited by-同舟云学术

Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations

Published:2012-05-26 Issue:3 Volume:11 Page:429-439
ISSN:1389-9600
Container-title:Familial Cancer
language:en
Short-container-title:Familial Cancer

Author:

de Bruin Monique A.,Kwong Ava,Goldstein Benjamin A.,Lipson Jafi A.,Ikeda Debra M.,McPherson Lisa,Sharma Bhavna,Kardashian Ani,Schackmann Elizabeth,Kingham Kerry E.,Mills Meredith A.,West Dee W.,Ford James M.,Kurian Allison W.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics(clinical),Oncology,Genetics

Link

http://link.springer.com/content/pdf/10.1007/s10689-012-9531-9.pdf

Reference54 articles.

1. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997) Cancer incidence in five continents, vol VII. IARC, Lyon

2. Son BH, Kwak BS, Kim JK et al (2006) Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years. Arch Surg 141:155–160

3. Yang L, Parkin DM, Ferlay J, Li L, Chen Y (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14:243–250

4. Yang L, Parkin DM, Li L, Chen Y (2003) Time trends in cancer mortality in China: 1987–1999. Int J Cancer 106(5):771–783

5. Yang L, Parkin DM, Li LD, Chen YD, Bray F (2004) Estimation and projection of the national profile of cancer mortality in China: 1991–2005. Br J Cancer 90(11):2157–2166

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRCA mutation status and pathological characterization of breast cancer in Zhoushan Islands, China;Journal of International Medical Research;2024-01

2. Genetic architecture of mammographic density as a risk factor for breast cancer: a systematic review;Clinical and Translational Oncology;2023-01-13

3. MAP3K1 rs889312 polymorphism and cancer prognosis: A systematic review and meta‐analysis;Cancer Reports;2022-12-22

4. Diagnostic and prognostic significance of SLC50A1 expression in patients with primary early breast cancer;Experimental and Therapeutic Medicine;2022-08-05

5. Teratogenicity;Reproductive and Developmental Toxicology;2022